Aucta Pharmaceuticals Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 184

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Investors
  • 14

Aucta Pharmaceuticals General Information

Description

Developer and provider of specialty pharmaceuticals and advanced drug delivery systems designed for central nervous system (CNS), respiratory, and ophthalmic therapeutic areas. The company provides integrated R&D, manufacturing, and commercialization services, enabling patients and healthcare providers with improved therapies through novel formulations, optimized dosing regimens, and new indications based on clinically validated molecules.

Contact Information

Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • Building Number 10, Number 100 Banxia Road
  • SIMZ Pudong
  • Shanghai, 201318
  • China
+86 021
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Building Number 10, Number 100 Banxia Road
  • SIMZ Pudong
  • Shanghai, 201318
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aucta Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. IPO 26-Jan-2026 Announced Generating Revenue
11. Secondary Transaction - Private 01-Dec-2025 Completed Generating Revenue
10. Secondary Transaction - Private 28-Sep-2022 Completed Generating Revenue
9. Later Stage VC (Series C1) 09-Oct-2021 Completed Generating Revenue
8. Secondary Transaction - Private 09-Oct-2021 Completed Generating Revenue
7. Later Stage VC (Series C) 30-Apr-2021 Completed Generating Revenue
6. Later Stage VC (Series B2) 31-Dec-2018 Completed Generating Revenue
5. Later Stage VC (Series B1) 31-Dec-2017 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2016 $4.86M Completed Generating Revenue
3. Early Stage VC (Series A) 03-Nov-2015 $4.72M $4.86M Completed Generating Revenue
To view Aucta Pharmaceuticals’s complete valuation and funding history, request access »

Aucta Pharmaceuticals Patents

Aucta Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12478587-B1 Formulation for lacosamide Active 06-Feb-2025
EP-4789660-A1 Novel formulation for lacosamide Pending 06-Feb-2025
US-20260224500-A1 Novel formulation for lacosamide Pending 06-Feb-2025
US-20260207539-A1 Pharmaceutical kit for preparation of ready-to-use vigabatrin solution Pending 21-Jan-2025
EP-4635477-A1 Composition containing lamotrigine, and preparation method and use thereof Pending 17-Apr-2024 A61K9/14
To view Aucta Pharmaceuticals’s complete patent history, request access »

Aucta Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aucta Pharmaceuticals Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
DNV Capital Venture Capital Minority
Baopu Capital Growth/Expansion Minority
C&D Emerging Industry Equity Investment Corporate Venture Capital Minority
Hidea Venture Capital Venture Capital Minority
Beijing Zhengtai Sunshine Equity Investment Fund Management Growth/Expansion Minority
You’re viewing 5 of 14 investors. Get the full list »

Aucta Pharmaceuticals FAQs

  • When was Aucta Pharmaceuticals founded?

    Aucta Pharmaceuticals was founded in 2012.

  • Where is Aucta Pharmaceuticals headquartered?

    Aucta Pharmaceuticals is headquartered in Shanghai, China.

  • What is the size of Aucta Pharmaceuticals?

    Aucta Pharmaceuticals has 184 total employees.

  • What industry is Aucta Pharmaceuticals in?

    Aucta Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Aucta Pharmaceuticals a private or public company?

    Aucta Pharmaceuticals is a Private company.

  • What is Aucta Pharmaceuticals’s current revenue?

    The current revenue for Aucta Pharmaceuticals is .

  • How much funding has Aucta Pharmaceuticals raised over time?

    Aucta Pharmaceuticals has raised $68.6M.

  • Who are Aucta Pharmaceuticals’s investors?

    DNV Capital, Baopu Capital, C&D Emerging Industry Equity Investment, Hidea Venture Capital, and Beijing Zhengtai Sunshine Equity Investment Fund Management are 5 of 14 investors who have invested in Aucta Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process